{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:02:49Z","timestamp":1791104569199,"version":"4.1.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7,1]]},"DOI":"10.1097\/qai.0b013e318050d683","type":"journal-article","created":{"date-parts":[[2007,4,20]],"date-time":"2007-04-20T04:05:06Z","timestamp":1177041906000},"page":"269-273","source":"Crossref","is-referenced-by-count":43,"title":["Pregnancy Rates and Birth Outcomes Among Women on Efavirenz-Containing Highly Active Antiretroviral Therapy in Botswana"],"prefix":"10.1097","volume":"45","author":[{"given":"Hermann","family":"Bussmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C William","family":"Wester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn N","family":"Wester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bright","family":"Lekoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okechukwu","family":"Okezie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Muir","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SM Victor","family":"DeGruttola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Makhema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Essex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G","family":"Marlink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210131","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(04)15997-7","article-title":"Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study.","volume":"363","author":"van Leth","year":"2004","journal-title":"Lancet"},{"key":"R2-3-20210131","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.qai.0000196667.24239.c2","article-title":"Antiretroviral therapy and congenital abnormalities in infants born to HIV-1-infected women in the United Kingdom and Ireland, 1990 to 2003.","volume":"42","author":"Townsend","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R3-3-20210131","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/01.qai.0000156854.99769.a5","article-title":"Does highly active antiretroviral therapy increase the risk of congenital abnormalities in HIV-infected women?","volume":"40","author":"Patel","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R5-3-20210131","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/archinte.162.3.355","article-title":"Periconceptional exposure to efavirenz and neural tube defects.","volume":"162","author":"De Santis","year":"2002","journal-title":"Arch Intern Med"},{"key":"R6-3-20210131","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/sj.jp.7211343","article-title":"Myelomeningocele in an infant with intrauterine exposure to efavirenz.","volume":"25","author":"Saitoh","year":"2005","journal-title":"J Perinatol"},{"key":"R8-3-20210131","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ajog.2004.05.061","article-title":"Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy.","volume":"191","author":"Watts","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R12-3-20210131","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.qai.0000219777.04927.50","article-title":"Tolerance and acceptability of an efavirenz-based regimen in 740 adults (predominantly women) in West Africa.","volume":"42","author":"Danel","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R13-3-20210131","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0029-7844(95)00399-1","article-title":"Pregnancy rates among women infected with human immunodeficiency virus. Adult\/Adolescent HIV Spectrum of Disease Project Group.","volume":"87","author":"Chu","year":"1996","journal-title":"Obstet Gynecol"},{"key":"R14-3-20210131","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00002030-199703110-00011","article-title":"Pregnancy and contraception in a French cohort of HIV-infected women. SEROCO Study Group.","volume":"11","author":"De Vincenzi","year":"1997","journal-title":"AIDS"},{"key":"R17-3-20210131","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1097\/00002030-200009290-00014","article-title":"Pregnancies before and after HIV diagnosis in a European cohort of HIV-infected women. European Study on the Natural History of HIV Infection in Women.","volume":"14","author":"van Benthem","year":"2000","journal-title":"AIDS"},{"key":"R18-3-20210131","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00002030-200401230-00018","article-title":"Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV.","volume":"18","author":"Massad","year":"2004","journal-title":"AIDS"},{"key":"R19-3-20210131","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/01.AOG.0000117083.33239.b5","article-title":"Trends in pregnancy rates among women with human immunodeficiency virus.","volume":"103","author":"Blair","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R20-3-20210131","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(02)09411-4","article-title":"Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.","volume":"360","author":"Egger","year":"2002","journal-title":"Lancet"},{"key":"R21-3-20210131","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-135-1-200107030-00005","article-title":"Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease.","volume":"135","author":"Murphy","year":"2001","journal-title":"Ann Intern Med"},{"key":"R23-3-20210131","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ar.1092030211","article-title":"A radiographic study of the longitudinal growth of primary ossification centers in limb long bones of the human fetus.","volume":"203","author":"Bagnall","year":"1982","journal-title":"Anat Rec"},{"key":"R25-3-20210131","first-page":"1243","article-title":"Management of spontaneous abortion.","volume":"72","author":"Griebel","year":"2005","journal-title":"Am Fam Physician"},{"key":"R26-3-20210131","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.qai.0000139398.38236.4d","article-title":"Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy.","volume":"38","author":"Tuomala","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R27-3-20210131","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/00002030-200411190-00019","article-title":"Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe.","volume":"18","author":"Thorne","year":"2004","journal-title":"AIDS"},{"key":"R28-3-20210131","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00126334-200304010-00006","article-title":"Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women.","volume":"32","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R29-3-20210131","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1097\/00002030-200012220-00013","article-title":"Combination antiretroviral therapy and duration of pregnancy.","volume":"14","year":"2000","journal-title":"AIDS"},{"key":"R30-3-20210131","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2307\/4065475","article-title":"Botswana: abortion debate dynamics.","volume":"12","author":"Mogwe","year":"1992","journal-title":"Agenda"},{"key":"R32-3-20210131","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1363\/3118305","article-title":"The incidence of induced abortion in Uganda.","volume":"31","author":"Singh","year":"2005","journal-title":"Int Fam Plan Perspect"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-200707010-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:36:13Z","timestamp":1786034173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-200707010-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,1]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318050d683","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7,1]]}}}